Molecular Targeted Therapy in Myelodysplastic Syndromes: New Options for Tailored Treatments

SIMPLE SUMMARY: Myelodysplastic syndromes (MDS) are a group of diseases in which bone marrow stem cells acquire genetic alterations and can initiate leukemia, blocking the production of mature blood cells. It is of crucial importance to identify those genetic abnormalities because some of them can b...

Descripción completa

Detalles Bibliográficos
Autores principales: Pagliuca, Simona, Gurnari, Carmelo, Visconte, Valeria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917605/
https://www.ncbi.nlm.nih.gov/pubmed/33668555
http://dx.doi.org/10.3390/cancers13040784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917605/
https://www.ncbi.nlm.nih.gov/pubmed/33668555
http://dx.doi.org/10.3390/cancers13040784

Ejemplares similares